RNA-Sequencing Vs. Microarrays
When, if ever, is using microarrays better than RNA-seq?
Gene expression Analysis is at the core of most of our projects at Genevia Technologies (more about our expression analyses here). There are two main assays yielding transcriptome-wide gene expression profiles of a tissue or culture, namely expression microarrays and next-generation RNA-sequencing.
A quick glance at Google Trends shows how microarrays, as a Google search topic, have steadily decreased in popularity since their heyday in the early 2000s. RNA-seq however, having been in wide use for much of the past decade, still continues its rise in popularity.
The switch: the popularity of Google search topics “Microarray” and “RNA-Seq” since 2004 illustrates the technological shift in transcriptomic measurements. (Source: Google Trends)
This technological switch in gene expression profiling is no surprise, considering what RNA-seq enables:
- detection of novel, unannotated genes
- detection of sequence-level alterations (coding region mutations, gene fusions, A-to-I editing events)
- detection of alternative splicing events, even novel ones, unlike with standard microarrays
- a broader dynamic range, adjustable by controlling the sequencing depth
- expression profiling of non-reference organisms (less straightforward but do-able!), and so on.
In most cases, obtaining the expression profile of your sample would still be a bit cheaper using microarrays instead of RNA-sequencing, the difference being in the range of 50 to 100 EUR/USD per sample. However, the benefits of RNA-seq can easily outweigh the extra cost.
Despite this, microarrays have not disappeared entirely. We regularly analyze microarray expression data for our customers (albeit not as much as RNA-seq). Researchers planning expression measurements still often ask our opinion on which technology to use.
The real question here is: when, if ever, does it make sense to use microarrays instead of RNA-sequencing?
Sometimes it does make sense. You might have a good reason to stick to microarrays, if 1) none of the parameters listed above is critical, and/or 2) one of the following applies:
- you use a microarray-based diagnostic test with proven clinical utility,
- you have a large number of samples and cost is critical,
- you want to be able to compare the expression profiles directly with another microarray data set of the same array platform, or
- you have a running microarray workflow in-house (or with trusted partners) from sample collection to data analysis that you are happy with
Finally, one point from a bioinformatician’s viewpoint that you might want to consider: if you have a researcher in your team who will use the data to learn bioinformatics, just remember that RNA-seq data analysis is definitely a more useful skill in modern (and future!) labs than microarray analysis.
The lists above should help you make the RNA-seq vs. microarray decision. However, it always pays to have a discussion with a bioinformatician or measurement provider in order to select the platform that best matches your biological material, research questions and budget.
Learn more about out service model or contact us to hear how we can help you!